Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,057 INR | -0.84% |
|
-2.96% | +53.29% |
06-14 | Zydus Lifesciences Gets US FDA's Tentative Approval for Generic Hypertension Drug | MT |
05-30 | India's pharma export sales to grow faster this year, trade body says | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.29% | 12.83B | |
+20.24% | 43.67B | |
+26.21% | 22.79B | |
+19.55% | 15.45B | |
+18.11% | 14.29B | |
-0.05% | 6.79B | |
-11.88% | 6.52B | |
+12.62% | 5.59B | |
-8.87% | 5.73B | |
+9.77% | 4.73B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Transcript : Cadila Healthcare Limited, Q3 2021 Earnings Call, Feb 05, 2021